Jessica Da Gama Duarte

Melbourne Austin Branch
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Tertiary lymphoid structures in head and neck squamous cell carcinoma as predictors of response to immunotherapy.

Tertiary lymphoid structures in head and neck squamous cell carcinoma as predictors of response to immunotherapy.

Journal: Oral oncology

Published: March 13, 2026

Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss.

Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss.

Journal: Clinical & translational immunology

Published: November 04, 2025

Defining the rules of engagement: B cells, antibodies and cancer control.

Defining the rules of engagement: B cells, antibodies and cancer control.

Journal: Cellular & molecular immunology

Published: October 17, 2025

Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers.

Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers.

Journal: BMJ oncology

Published: April 20, 2025

Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review.

Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review.

Journal: Translational lung cancer research

Published: April 15, 2025

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.

Journal: Frontiers in immunology

Published: August 02, 2024

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.

Journal: Journal for immunotherapy of cancer

Published: August 31, 2021

Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.

Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.

Journal: International journal of molecular sciences

Published: August 31, 2021

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.

Journal: Cancers

Published: March 22, 2021

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 20, 2020

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

Journal: Frontiers in immunology

Published: December 15, 2017

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

Journal: Immunology and cell biology

Published: October 13, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026